Skip to main content
Clinical Trials/NL-OMON50216
NL-OMON50216
Recruiting
Not Applicable

Distal Evaluation of Functional performance with Intravascular sensors to assess the Narrowing Effect - Combined pressure and Doppler FLOW velocity measurements - DEFINE FLOW

niversity of Texas Medical School at Houston0 sites100 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
atherosclerosis
Sponsor
niversity of Texas Medical School at Houston
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
niversity of Texas Medical School at Houston

Eligibility Criteria

Inclusion Criteria

  • 3\.1 Inclusion Criteria, 3\.1\.1 Age \>\= 18 years., 3\.1\.2 Eligible for PCI based on
  • local practice standards during the current procedure (PCI cannot be staged).,
  • 3\.1\.3 At least one epicardial stenosis of \>\=50% diameter (by visual or
  • quantitative assessment) and meeting the following criteria as determined by
  • the operator based on either a prior or the current diagnostic angiogram:
  • \<100% diameter (not a chronic, total occlusion);
  • in a native coronary artery (including side branches but excludes bypass
  • of \>\=2\.5mm reference diameter (near the level of the stenosis);
  • and supplies sufficiently viable myocardium (exclude regions of known, prior,
  • transmural myocardial infarction)., 3\.1\.4 Ability to understand and the

Exclusion Criteria

  • Anatomic exclusions:, 3\.2\.1 Prior CABG., 3\.2\.2 Preferred treatment strategy for
  • revascularization would be CABG based on local practice standards., 3\.2\.3 Left
  • main coronary artery disease requiring revascularization., 3\.2\.4 Extremely
  • tortuous or calcified coronary arteries precluding intracoronary physiologic
  • measurements. Operators may also exclude subtotal or similar high\-grade
  • lesions, which in their judgment may be threatened by ComboWire placement.,
  • 3\.2\.5 Known severe LV hypertrophy (septal wall thickness at echocardiography of
  • \>13 mm)., Clinical exclusions:
  • 3\.2\.6 Inability to receive intravenous adenosine (for example, severe reactive
  • airway disease, marked hypotension, or high\-grade AV block without pacemaker).,

Outcomes

Primary Outcomes

Not specified

Similar Trials